Ligand Bias at Metabotropic Glutamate 1a Receptors: Molecular Determinants That Distinguish β-Arrestin-Mediated from G Protein-Mediated Signaling-Reference-Cited by-同舟云学术

Ligand Bias at Metabotropic Glutamate 1a Receptors: Molecular Determinants That Distinguish β-Arrestin-Mediated from G Protein-Mediated Signaling

Published:2012-05-14 Issue:2 Volume:82 Page:291-301
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Emery Andrew C.,DiRaddo John O.,Miller Eric,Hathaway Hannah A.,Pshenichkin Sergey,Takoudjou Guy Rodrigue,Grajkowska Ewa,Yasuda Robert P.,Wolfe Barry B.,Wroblewski Jarda T.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference29 articles.

1. A critical pocket close to the glutamate binding site of mGlu receptors opens new possibilities for agonist design

2. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluRl, in transfected CHO cells

3. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death

4. Group I metabotropic glutamate receptor activation increases phosphorylation of cAMP response element-binding protein, Elk-1, and extracellular signal-regulated kinases in rat dorsal striatum;Choe;Brain Res Mol Brain Res,2001

5. (+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SCA44‐ and SCAR13‐associated GRM1 mutations affect metabotropic glutamate receptor 1 function through distinct mechanisms;British Journal of Pharmacology;2024-07-19

2. CMV-encoded GPCRs in infection, disease, and pathogenesis;Advances in Virus Research;2024

3. SCA44- and SCAR13-associatedGRM1mutations affect metabotropic glutamate receptor 1 function through distinct mechanisms;2023-07-05

4. Rigorous Characterization of Allosteric Modulation of the Human Metabotropic Glutamate Receptor 1 Reveals Probe- and Assay- Dependent Pharmacology;MOL PHARMACOL;2023

5. Oscillatory Deficits in the Sub-Chronic PCP Rat Model for Schizophrenia Are Reversed by mGlu5 Receptor-Positive Allosteric Modulators VU0409551 and VU0360172;Cells;2023-03-16